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ABSTRACT 
In the present research work mixed hydrotropic solubilization phenomenon is used to enhance the solubilization of poorly water 
soluble drugs. Bulk drug samples were identified by the observed IR spectra and the melting points determination. Sodium benzoate, 
niacinamide and urea are the hydrotropes were selected for the solubility enhancement of drugs Solubility enhancement ratios for 
selected poorly water-soluble drugs were determined. Results showed that remarkable increase in aqueous solubility of Miconazole 
in presence of large concentration of hydrotropes. Marketed Miconazole tablets determined by spectrophotometric analysis using 
hydrotropic solubilization techniques. Validation of the proposed analysis methods  is  confirmed  by  satisfactorily  low  values  of  
statistical  parameters  viz., standard deviation, percent coefficient of variation and standard error. 
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INTRODUCTION 
In the present research work mixed hydrotropic 
solubilization phenomenon is used to enhance the 
solubilization of poorly water soluble drug (Miconazole). 
The solubility of drugs of pharmaceutical formulation in 
water is very great problem of present day. There are so 
many techniques or methods are used nowadays to 
increase the solubility of different pharmaceutical 
preparations
1
. Use of Solid dispersion
2,3
, cyclodextrin
4
 
and polysaccharide chitosans
5
, dendrimers
 6
, preparation 
of buffers, Liquisolid techniques
7
, complex formation, 
chelation and salting in are different procedures to 
increase the solubility of active constituents. Different 
solubilization techniques have various advantage and 
disadvantage in the formulations. Hydrotropic 
solubilization is one of the techniques that are used to 
increase aqueous solubility of different dosages forms in 
pharmaceutical industry.  
In hydrotropic solubilization a large amount of 
hydrotropic agents like urea, sodium benzoate, sodium 
citrate, sodium salicylate, sodium alginate, nicotinamide, 
glycine etc are used in parts by agitating the solution 
vigorously adding agents after regular intervals. The 
hydrotropes forms agglomerates with drugs to dissolve 
and salting in phenomena takes place in the mechanism. 
The hydrotropes are eco-friendly, cheap and harmless to 
the preparations as compared to organic solvents such as 
chloroform, methanol, petroleum ether etc. that are toxic 
to environment, very costly, inflammable and evaporable. 
The organic solvents are hazardous to environment as 
compared to hydrotropes. 
Mixed hydrotropic solubilization is now more advanced 
version of hydrotropic solubilization. In this technique 
two or more hydrotropes are taken in different ratios to 
increase the solubility of the drug. Itself pharmaceutical 
ingredient also acts as hydrotropes to increase the 
solubility of other drugs. The hydrotropes form 
agglomerates and increase the solubility of different 
pharmaceutical formulations by salting in mechanism.  
From literature survey, it is evident that urea has been 
extensively employed to make solid dispersions of a 
large number of poorly water-soluble drugs (by fusion 
or common solvent technologies). As evident from 
solubility studies,  urea has been found to enhance 
aqueous solubility of Miconazole significantly.  
Therefore, this poorly water-soluble drugs and urea as 
a model hydrotropic agent selected to prepare 
hydrotropic solid dispersions for solubility enhancement 
study. The prepared solid dispersions have been 
characterized by DSC, XRD and IR studies. They have 
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been studied for dissolution rate enhancement effect and 
stability as well. 
METHODS 
Identification of bulk drug samples 
The bulk drug samples were identified by matching 
their IR spectra. The instrument used for this purpose 
was, FTIR-8400 S, Shimadzu Corporation (Japan). 
Further, confirmation of drugs was done by observing 
their melting points (by Thiele’s tube method). The 
observed melting points of these drugs were matching 
with the reported melting points. 
Selections of hydrotropes for poorly water-soluble 
drugs 
From the literature survey evident that more is the 
concentration of hydrotropes, more is the aqueous 
solubility of drugs. Therefore, concentrated 
a q u e o u s  solutions   of s o m e  hydrotropes  w e r e  
utilized in this study. 2 M sod. Benzoate (2 M SB), 2 
M sod. Salicylate, 2 M niacinamide (2 M NM), (2 M 
SS), 4 M sodium acetate (4 M SA), 10 M urea and 
1.25 M sodium citrate (1.25 M SC) (10 M UR) were 
used as hydrotropic solutions. 
In order to select best hydrotropes for various   drugs,   
an approximate solubility determination method was 
employed.  This process is a modified form of the 
process used by Simamora et al
8
. When the determined 
solubility enhancement ratio was at least 5, such 
hydrotropic solution was selected for that drug (Table 1). 
Table 1: Hydrotropes selected for poorly water-
soluble drugs 
Drugs Selected hydrotropic solution 
Miconazole 2 M Sodium benzoate 
Miconazole 2 M Niacinamide 
Miconazole 10 M Urea 
 
Determination of interference of hydrotropic agents 
in the spectrophotometric estimation of drugs
9
 
A UV-visible recording spectrophotometer (model 
UV-160 A; Shimadzu, Japan) with 1 cm matched silica 
cells was employed for spectrophotometric 
determinations. For determination of interference of 
hydrotropes in the spectrophotometric estimation of 
miconazole, the absorbance of the Std solutions of 
drugs were measured in distilled  water only and in 
the presence of the highest concentration of the 
hydrotropic agent employed for spectrophotometric 
analysis/formulation  aim  in  the  this study.  
Absorbances of drug were recorded against respective 
reagent blanks at appropriate wavelengths and results 
are presented in Table 2. 
Determination of interference   of   formulation   
additives in the spectrophotometric estimation of 
drugs 
For determination  of interference of formulation 
additives in the spectrophotometric  estimation 
of  miconazole, the absorbance  of  the  standard  
solutions  of  drugs  were  determined  in  presence  of 
maximum concentrations of formulation additives 
employed for formulation purpose in the  present 
investigation. The absorbance were recorded against 
respective reagent blanks at appropriate 
w a v e l e n g t h s  and results are presented in table 2 
and 3 
Regression Equation for Miconazole in Distilled 
Water 
50 mg miconazole bulk drug was accurately weighed 
and transferred to a 500 ml volumetric flask. 
Distilled water (450 ml) was added and flask was 
shaken vigorously to dissolve the drug. Absorbance 
values of these solutions were noted at 320 nm against 
distilled water blank. These values of absorbance of 
standard solutions were used to obtain regression 
equation (Table 4). 
Regression Equations for Miconazole in Presence of 
Hydrotropic Agents (Sodium benzoate, Niacinamide 
and Urea) 
50 mg of drug was accurately weighed and transferred 
to a 500 ml volumetric flask. Twenty ml of 2 M sod 
benzoate solution was incorporated and then drug was 
added in this solution and dissolved by shaking. 
Absorbance values of these solutions were measured at 
320 nm against their respective reagent blanks. The 
values of absorbance of std solutions were utilized to 
g e t  reg.  eq. (Table 4) for the determination of 
miconazole in presence of sod. benzoate. 
Essentially same procedure was repeated using 2 M 
niacinamide and 10 M urea solutions in place of 2 M 
sodium benzoate solution to obtain regression equation 
(Table 3) for the estimation of miconazole in presence of 
niacinamide and urea. 
The regression equations so obtained, the wavelengths 
selected and the concentrations of various hydrotropic 
solutions used (Beer’s ranges) are shown in Table 4. 
Equilibrium solubility determinations at room 
temperature 
A method
 
was employed for determination of 
equilibrium solubility at room temperature. Filtrates of 
saturated solutions of miconazole were measured on 
spectrophotometer, determining the absorbance of 
diluted solutions (with distilled water) against the 
respective reagent blanks at their appropriate 
wavelengths (Table 4).  Solubility so determined 
have been shown in Table 5. 
Enhancement ratios (Table 5) in solubility were 
determined by following formula - 
Enhancement   ratio=  
Solubility in hydrotropic solution/Solubility in distilled 
water 
Spectrophotometric analyses of marketed tablet 
formulations of miconazole using hydrotropic 
solubilization technique 
20 marketed tablets of miconazole (formulation-I) 
were weighed and ground to a fine powder. An 
accurately weighed tablet powder equivalent to 50 mg of 
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miconazole was transferred to a 25 ml volumetric flask. 
Then 20 ml of 2 M sodium benzoate solution was 
added and the flask was shaken for about 10 min to 
solubilize the drug present in tablet powder and the 
required volume was made up by adding distilled water. 
Filtrate was collected, and first few ml of solution was 
rejected then this filtered solution was divided in 2 parts 
A and B. 
To check its chemical stability and to observe 
precipitation, Part A was kept at room temp for 48 
hours, if any. F u r t h e r ,  Part B filtrate was diluted 
b y  a d d i t i o n  o f  distilled water and was analyzed 
on uv-spectrophotometer against reagent blank by 
noting the absorbance at 320 nm. The drug content of 
the tablet formulation-I was calculated using reg. eq. 
(Table 4). The results of analysis are presented in Table 
6. After 48 hours, filtrate of part A was analyzed in 
the same way, to test the chemical stability of drug 
in presence of hydrotrops (Na-benzoate). 
After first analysis, same procedure was repeated for 
five times more. In these cases, filtrates were not 
divided in two parts. Filtrates were analyzed in fresh 
conditions only. Using the same procedure the drug 
contents of tablet formulation-I were calculated and 
results of analysis are presented in Table 6. The 
statistical evaluation of results of analysis is presented in 
Table 7. 
Recovery studies of marketed miconazole tablet 
formulations using hydrotropic solubilization 
technique 
In  order  to  validate  the  proposed  method,  the  
recovery  studies  were performed. For this, pre-
analyzed tablet powder equivalent to 50 mg of 
miconazole was accurately weighed and transferred to a 
25 ml volumetric flask. Then, 10 mg of miconazole 
bulk drug sample was added to this volumetric flask, 
as spiked drug. Then, 20 ml of 2 M sodium benzoate 
solution was added and the flask was shaken for about 
10 min and the volume was made up to the mark 
with distilled  water. After stirring the contents of 
flask for mixing of contents, contents were filtered 
using Whatman filter #41.  Then, First few ml of 
collected filtered solution was rejected. The filtrate was 
appropriately diluted by addition of distilled water and 
absorbance of this solution was measured at 320 nm 
against respective reagent blank. The recovery studies 
were performed for six times (using 10 mg spiked 
drug) and the results of recovery analysis are presented 
in Table 8. Similar recovery studies were performed 
using 20 mg of miconazole bulk drug sample as the 
spiked drug and results are presented in Table 8. 
Just like   marketed   tablets   of   formulation-I,   the   
marketed   tablets   of formulation-II was subjected to 
analysis (using 2 M sodium benzoate solution) and the 
results are presented in table 6, 7 and Table 8.. 
Another hydrotropic  agent,  2  M  niacinamide  
solution  was  also  used  for spectrophotometric   
estimation  of   marketed  tablet   formulations  (I   and   
II)   of miconazole in the same manner as in the case 
of 2 M sodium benzoate solution method, as per the 
conditions mentioned in Table 4.33. The results of 
analysis are presented in table 6, 7 and Table 9. 
Preparation of Hydrotropic Solid Dispersions of 
Miconazole
10. 11
 
Accurately weighed 5.0 g miconazole and 20.0 g urea 
were employed to  prepare solid dispersion containing 
miconazole and urea in ratio of 1:4 (MU 1:4HSD). 
Similarly, 5.0 g miconazole, 30.0 g urea and 5.0 g 
miconazole, 40.0 g urea were used to prepare solid 
dispersions containing miconazole and urea in ratios of 
1:6 (MU 1:6 HSD) and 1:8 (MU 1:8 HSD), respectively. 
Preparation of Physical Mixtures of Miconazole 
To prepare physical mixture containing miconazole and 
urea in ratio 1:8  (AU 1:8 PM), accurately weighed 5.0 
g miconazole and 40.0 g urea were triturated intensely 
for 10 min using glass pestle and  mortar. Then, 
powder mass was shifted through sieve # 100. 
Determination of Drug Content in Miconazole in 
physical mixtures (PM) and hydrotropic solid 
dispersions (HSD)
 10. 11
 
Powdered solid dispersion containing about 10 Mg of 
miconazole (drug) was weighed and transferred to a 
500 ml vol flask. About  450  ml  of  distilled  water  
was  added  and  content of this flask  was  stirred  to  
dissolve  the solid dispersion completely. Now volume 
was produced up to the required volume with dist 
water and the absorbance was noted at 320 nm against 
reagent blank. In each case, analysis was carried out in 
triplicate. The drug content was determined using 
regression equation Y = 0.0551 X – 0.0075 (Table 4). 
The results of analysis are presented in Table 12. 
IR studies of formulations of drugs 
A large number of solid dispersions have been 
characterized by IR studies
  
to assess the possibility of 
interaction between drugs and water-soluble carriers. 
Attempts were made to assess the possibility of 
interaction of hydrotropic agent, urea with drug 
miconazole by conducting IR studies on the prepared 
drug formulations, HSD and PM both. 
DSC studies of drugs and their formulations 
A large number of solid dispersions have been 
characterized by DSC studies to assess the possibility of 
interactions between drugs and water-soluble carriers. 
Attempts were made to assess the possibility of 
interaction of hydrotropic agent, urea with miconazole 
by conduct ing DSC studies. 
In order to obtain the DSC thermograms of the drugs and 
their formulations (HSD and PM), a thermal analysis 
instrument, TA Instruments-2910 modulated DSC 
(USA) was employed. To carry out these studies, 1-4 
mg of drug or formulation of drug was weighed 
accurately and placed in one of the matched aluminium 
pan. The sample pan and the reference pan both were 
sealed and placed on the heating cell and covered with a 
glass bell jar. Heating at a rate of 10
o
C/min with a 
continuous purge of nitrogen (45 CC/min) was done 
with recording of energy changes in the sample with 
respect to the reference in the temperature range of 
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80-200
o
C.  
Powder X-ray diffraction studies of drugs and their 
formulations 
The powder X-ray diffraction spectra of urea, 
miconazole, the prepared HSD and PM were found 
using  RU-H3R, Horizontal Rotaflex 
rotating anode X-ray generator instrument, Rigaku 
(Rigaku International Corporation, Tokyo). The powder 
was spread on a graticule and pressed in such a way that 
powder did not fall on keeping the graticule vertical. 
The graticule was placed in sample holder and exposed 
to CuKα-radiation (40 KV, 50 MA), 2θ = 5
°  
to 40
°  
at 
a scanning speed 4
°
/min and step size 0.02
°  
2θ. The X-
ray diffractograms so obtained are presented in Fig. 
1 to Fig. 6. The major characteristic X-ray 
diffractogram peaks are presented in Table 13. 
Dissolution rate studies of drugs and their 
formulations 
Dissolution  rates  of  bulk  drug  samples  miconazole, physical mixtures containing drug:urea of 1:8 ratio of miconazole and urea of 1:12 ratio and all hydrotropic solid dispersions of drug were studied using USP XXIV (type II) dissolution  rate  test  apparatus  (Model-TDT  6P,  Electrolab,  Mumbai,  India)  using  a paddle  stirrer. Distilled water (900 ml) was used as 
dissolution medium. Bulk drug samples, physical 
mixtures and hydrotropic solid dispersions equivalent to 
200 mg drug were used to perform dissolution rate 
studies. The stirrer was adjusted to rotate at 50 rpm. A 
temperature of 37 ± 0.5
o
C was maintained throughout 
the experiments. Calculations for amounts  o f  drugs  
released were done using respective reg. equations 
(Table 4). The observation of dissolution studies are 
shown in the Fig. 7. 
Stability studies of drug formulations 
The physical mixtures (of drugs with urea) were 
subjected to chemical stability and the chemical 
stabilities. The percent residual drug for each 
formulation at different time intervals is recorded in 
Table 14. 
RESULTS AND DISCUSSION 
Bulk drug samples were identified by the observed IR 
spectra and the melting points determination. Based 
on an approximate solubility determination method, 
suitable hydrotropes were selected for the poorly water-
soluble drugs (Table 1). 
It is evident from Table 2 that there is no or 
negligible interference on the absorbance values of 
drug solutions in presence of hydrotropic agents. Also, it 
is evident from Table 3 that there is no or negligible 
interference on the absorbance values of drug 
solutions in presence of formulation additives. 
For spectrophotometric estimations of miconazole, 
the regression equations were determined (Table 4). The 
observed values of R (correlation coefficient) were 
approaching 1, indicating good linear relationships. 
Solubility en hancement  r a t i o s  for selected poorly 
water-soluble drugs were determined (Table 5) and 
ranged in between 5.1 to 10.9 and 6.1 to 7.1.
 
Table 2:  Interference studies for hydrotropic agents 
Drug Solvent system 
used 
Concentration of 
drug used (µg/ml) 
Concentration of 
hydrotropes used (µg/ml) 
Wavelength 
(nm) 
Absorbance 
against respective 
blank 
Miconazole DW 20 - 320 1.089 
Miconazole DW + SB 20 2300 320 1.090 
Miconazole DW + NM 20 1950 320 1.087 
Miconazole DW + UR 20 4800 320 1.072 
SB-Sodium benzoate, NM-Niacinamide, UR-Urea, SC-Sodium citrate, DW-Distilled water 
Table 3: Interference studies for formulation additives 
Drug Solvent system 
used 
Concentra- tion of 
drug used (µg/ml) 
Concentration of 
additive used 
(µg/ml) 
Wave length 
(nm) 
Absorbance against 
respective blank 
Miconazole DW 20 - 320 1.089 
Miconazole DW + Glycerin 20 100 320 1.079 
Miconazole DW + Sucrose 20 200 320 1.083 
DW-Distilled water 
Table 4: Optical characteristics for uv-spectrophotometric determination of drugs using different solvent 
systems 
DW-Distilled water, SB-Sodium benzoate, NM-Niacinamide, UR-Urea, SC-Sodium citrate 
Drug Solvent system    Wavelength used (nm) Beer’s range (µg/ml) Regression equation R 
Miconazole DW 320 5 – 30 Y = 0.0548 X – 0.0017 0.9999 
Miconazole DW + SB 320 5 – 30 Y = 0.0548 X – 0.0015 0.9998 
Miconazole DW + NM 320 5 – 30 Y = 0.0551 X – 0.0021 0.9998 
Miconazole DW + UR 320 5 – 30 Y = 0.0551 X – 0.0075 0.9996 
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Table 5: Solubility of drug in different aqueous systems at room temperature 
Drug Solvent system Method of 
analysis used 
Solubility 
(% w/v) 
Temperature 
(
o
C) 
Solubility 
enhancement ratio 
Miconazole DW SPM 0.728 28 ± 1 - 
Miconazole 2 M SB SPM 3.783 28 ± 1 5.2 
Miconazole 2 M NM SPM 7.941 28 ± 1 10.9 
Miconazole 10 M UR SPM 3.682 28 ± 1 5.1 
DW-Distilled water, SB-Sodium benzoate, NM-Niacinamide, UR-Urea, SC-Sodium citrate, SA-Sodium acetate, SS-Sodium salicylate, TM-
Titrimetric method, SPM- 
 
In the present investigation Miconazole having poor 
aqueous solubility has been selected as model drugs. 
Hydrotropic solubilization phenomenon has been used 
to analyze these drugs without the help of organic 
solvents.  
As evident from Table 5, there is remarkable increase in 
aqueous solubility of Miconazole in presence of large 
concentration of hydrotropes. Thus, it was thought 
worthwhile to make use of hydrotropic solubilization 
techniques for the development of new 
spectrophotometric analytical techniques. 
Spectrophotometric analyses of marketed tablet 
formulations of miconazole using hydrotropic 
solubilization technique 
The statistical evaluation of results of analysis is 
presented in Table 7. 
Recovery studies of marketed miconazole tablet 
formulations using hydrotropic solubilization 
technique 
The recovery studies were performed for six times 
(using 10 mg spiked drug) and the results of 
recovery analysis are presented in Table 8. Similar 
recovery studies were performed using 20 mg of 
miconazole bulk drug sample as the spiked drug and 
results are presented in Table 8. 
Just l i k e    marketed   tablets   of   formulation-I,   the   
marketed   tablets   of formulation-II was subjected to 
analysis (using 2 M sodium benzoate solution) and the 
results are presented in Table 6, 7 and Table 8. 
Another hydrotropic  agent,  2  M  niacinamide  
solution  was  also  used  for spectrophotometric   
estimation  of   marketed  tablet   formulations  (I   and   
II)   of miconazole in the same manner as in the case 
of 2 M sodium benzoate solution method  (Section 4.7 
and 4.8), as per the conditions mentioned in Table 
4.33. The results of analysis are presented in 6, 7 and 
Table 9.
 
Table 6:  Results of spectrophotometric analysis of miconazole tablet formulations SBM-Sodium benzoate 
method, NMM-Niacinamide method 
 
Table 7: Statistical evaluation of spectrophotometric analysis of miconazole tablet formulations 
Tablet 
formu 
-lation 
SBM NMM 
Mean % 
estimated 
Standard 
deviation 
% Coeff. of 
variation 
Stan- dard 
error 
Mean % 
estimated 
Standard 
deviation 
% Coeff. of 
variation 
Stan- 
dard 
error 
I 100.27 0.784 0.782 0.320 101.44 1.120 1.104 0.457 
II 99.65 0.872 0.875 0.356 98.96 1.086 1.097 0.443 
SBM-Sodium benzoate method, NMM-Niacinamide method. 
Amount of 
drug present in 
tablet powder 
analyzed (mg) 
Amount found (mg) Percentage estimated 
Formulation-I Formulation-II Formulation-I Formulation-II 
SBM NMM SBM NMM SBM NMM SBM NMM 
50 49.76 51.42 50.29 49.03 99.52 102.84 100.58 98.06 
50 50.56 50.24 49.63 49.96 101.12 100.48 99.26 99.92 
50 49.90 51.06 49.33 50.31 99.80 102.12 98.66 100.62 
50 50.04 49.93 50.16 49.39 100.08 99.86 100.32 98.78 
50 50.69 50.65 49.36 49.26 101.38 101.30 98.72 98.52 
50 49.86 51.03 50.18 48.93 99.72 102.06 100.36 97.86 
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Table 8: Results of recovery studies of spectrophotometric analysis of miconazole tablet formulations 
u s i n g  s o d i u m  b e n z o a t e  solution (n=6) 
 
Table 9:  Results of   recovery s t u d i e s  of spectrophotometric analysis of miconazole tablet formulations 
using niacinamide solution (n=6) 
Tablet formu- 
lation 
Drug present in pre- 
analyzed tablet 
powder taken (mg) 
Pure drug 
added (spiked) 
(mg) 
% Recovery estimated 
(mean ± S.D.) 
% 
Coeff. of 
variation 
Standard error 
I 50 10 98.88 ± 0.762 0.771 0.311 
I 50 20 99.49 ± 2.339 2.351 0.955 
II 50 10 99.67 ± 1.050 1.053 0.429 
II 50 20 98.59 ± 0.950 0.963 0.388 
 
Table 7 denotes that the mean percent estimations of 
miconazole tablets determined by spectrophotometric 
analysis using hydrotropic solubilization techniques 
(by use of 2 M sodium benzoate solution and 2 M 
niacinamide solution) ranged from 98.96 to 101.44. 
Observed values of mean percent estimation are very 
close to 100, indicating the accuracy of the proposed 
methods. Low values of standard deviation (0.784 to 
1.120), percent coefficient of variation (0.782 to 1.104) 
and standard error (0.320 to 0.457) validated the 
proposed methods of analysis. Table 8 and Table 9 
show that mean percent recoveries estimated using the 
proposed methods ranged from 98.59 to 101.77, which 
are again very close to 100, indicating the accuracy of 
the proposed method. Validation of the proposed 
analysis methods  is  confirmed  by  satisfactorily  low  
values  of  statistical  parameters  viz., standard 
deviation (0.762 to 2.339), percent coefficient of 
variation (0.770 to 2.351) and standard error (0.311 to 
0.955). 
Like above explanation, the other proposed methods 
employed for spectrophotometric estimations of 
marketed tablets   of miconazole a r e  very well 
validated (Table 10, 11). 
 
Table 10: Observed values of mean percent estimation, standard deviation, percent coefficient of variation and 
standard error, obtained in spectrophotometric analysis of marketed tablets of drugs using proposed 
hydrotropic solubilization techniques 
Tablets analyzed Method of 
analysis 
Mean % 
estimated 
Standard 
deviation 
% Coeff. of 
variation 
Standard 
error 
Reference table 
number 
Miconazole SBM 100.27, 
99.65 
0.784, 
0.872 
0.782, 
0.875 
0.320, 
0.356 
4.30 
Miconazole NMM 101.44, 
98.96 
1.120, 
1.086 
1.104, 
1.097 
0.457, 
0.443 
4.30 
SBM-Sodium benzoate method, NMM-Niacinamide method, URM-Urea method 
 
 
 
 
 
Tablet 
formulation 
Drug present in pre-
analyzed tablet 
powder taken (mg) 
Pure drug 
added 
(spiked) (mg) 
% Recovery estimated 
(mean ± S.D.) 
% Coeff. of 
variation 
Standard error 
I 50 10 98.87 ± 1.321 1.336 0.539 
I 50 20 99.22 ± 0.912 0.919 0.372 
II 50 10 100.37 ± 0.773 0.770 0.316 
II 50 20 101.77 ± 1.103 1.084 0.450 
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Table 11: Ranges of mean percent recoveries, standard deviation, percent coefficient of variation and 
standard error, obtained in spectrophotometric analysis of marketed tablets of drugs using proposed 
hydrotropic solubilization techniques 
Tablets analyzed Method of 
analysis 
Range of mean 
% recovery 
estimated 
Range of 
standard 
deviation 
Range of 
% coeff. of 
variation 
Range of 
standard 
error 
Refer- ence 
table number 
Miconazole SBM 98.87 to 
101.77 
0.773 to 
1.321 
0.770 to 
1.336 
0.316 to 
0.539 
4.31 
Miconazole NMM 98.59 to 
99.67 
0.762 to 
2.339 
0.771 to 
2.351 
0.311 to 
0.955 
4.32 
SBM-Sodium benzoate method, NMM-Niacinamide method, URM-Urea method 
 
From literature survey, it is evident that urea has been 
extensively employed to make solid dispersions of a large 
number of poorly water-soluble drugs (by fusion or 
common solvent technologies). As evident from 
solubility studies (Table 5), urea has been found to 
enhance aqueous solubility of miconazole significantly.  
Therefore, this poorly water-soluble drug and urea as a 
model hydrotropic agent selected to prepare hydrotropic 
solid dispersions for solubility enhancement study. The 
prepared solid dispersions have been characterized by 
DSC, XRD and IR studies. They have been studied for 
dissolution rate enhancement effect and stability as well. 
Determination of Drug Content in physical mixtures 
(PM) and hydrotropic solid dispersions (HSD) 
The drug content was determined using regression 
equation Y = 0.0551 X – 0.0075 (Table 4). The 
results of analysis are presented in Table 12. 
 
Table 12: Drug contents of  physical mixtures  and hydrotropic solid dispersions (n=3) 
 
Drug Drug : Urea ratio Percent drug content (mean ± S.D.) 
PM HSD 
Miconazole 1 : 4 18.93 ± 0.981 18.75 ± 0.808 
1 : 6 13.83 ± 0.638 13.89 ± 0.930 
1 : 8 10.99 ± 1.386 10.91 ± 1.008 
1 : 10 8.82 ± 0.898 8.64 ± 1.061 
1 : 12 7.44 ± 1.333 7.39 ± 1.218 
PM-Physical mixture, HSD-Hydrotropic solid dispersion 
 
IR studies of formulations of drugs 
A large number of solid dispersions have been 
characterized by IR studies to assess the possibility of 
interaction between drugs and water-soluble carriers. 
Attempts were made to assess the possibility of 
interaction of hydrotropic agent, urea with drugs 
miconazole by conducting  IR studies on the 
prepared drug formulations, HSD and PM both (Fig. 5.1 
to Fig. 5.9). The instrument used for this purpose was,   
FTIR-8400 S, Shimadzu Corporation, Japan.  
Formulations containing highest proportion of urea 
were employed for these studies. 
 
DSC studies of drugs and their formulations 
A large number of solid dispersions have been 
characterized by DSC studies to assess the possibility 
of interactions between drugs and water-soluble 
carriers.  
Powder X-ray diffraction studies of drugs and their 
formulations 
The powder X-ray diffraction spectra of urea, 
miconazole, the prepared HSD and PM were found 
using  RU-H3R, Horizontal Rotaflex 
rotating anode X-ray generator instrument, Rigaku 
(Rigaku International Corporation, Tokyo). The X-ray 
diffractograms so obtained are presented in Fig. 1 to 
Fig. 6. The major characteristic X-ray diffractogram 
peaks are presented in Table 13. 
Dissolution rate studies of drugs and their 
formulations 
Calculations for amounts  o f  drugs released were 
done using respective reg. equations (Table 4). The 
observation of dissolution studies are shown in the Fig 
7. 
 
Chemical Stability Testing of Hydrotropic Solid 
Dispersions and Physical Mixtures of Drugs 
The physical mixtures (of drugs with urea) were 
subjected to chemical stability and the chemical 
stabilities. The percent residual drug for each 
formulation at different time intervals is recorded in 
Table 14. 
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Table 13: X-ray diffraction peaks (major) for miconazole and urea systems (2θ values) 
 Miconazole MU 1:8 PM MU 1:8 HSD 
8.98 12.34 12.48 10.70 
20.80 13.92 14.02 22.04 
21.96 21.70 21.72 22.46 
23.62 24.92 22.12 24.58 
24.36 27.50 22.56 29.32 
26.52 29.42 24.74 31.70 
27.96 33.44 29.46 35.64 
28.34 - 31.82 37.16 
30.32 - 35.72 - 
31.34 - - - 
35.26 - - - 
39.42 - - - 
 
 
Table 14: Chemical stability data of miconazole hydrotropic solid dispersions and physical mixture 
 
Condition Time 
(months) 
Percent residual drug in formulations (mean ±  S.D.) 
MU 1:4HSD MU 1:6 HSD MU 1:8 HSD MU 1:8 PM 
Room temperature 1 99.69 ± 1.339 99.88 ± 0.699 99.90 ± 0.599 99.82 ± 1.339 
Room temperature 3 99.52 ± 0.699 99.72 ± 1.387 99.79 ± 0.769 99.65 ± 0.699 
Room temperature 6 99.38 ± 1.089 99.24 ± 1.488 99.48 ± 1.337 99.53 ± 0.760 
40
o
C/75% RH 
1 99.46 ± 0.779 99.61 ± 0.919 99.52 ± 0.941 99.39 ± 0.951 
40
o
C/75% RH 
3 99.16 ± 0.831 99.02 ± 1.380 98.89 ± 1.137 98.97 ± 0.888 
40
o
C/75% RH 
6 97.44 ± 1.530 97.89 ± 1.209 97.77 ± 0.843 97.86 ± 1.677 
55
o
C 
1 99.38 ± 2.376 99.36 ± 0864 99.15 ± 0.763 99.28 ± 0.921 
55
o
C 
3 98.45 ± 0.665 98.27 ± 1.490 98.42 ± 1.088 98.39 ± 0.776 
55
o
C 
6 96.16 ± 0.843 96.05 ± 0.677 96.21 ± 1.320 96.81 ± 1.144 
 
The  IR  spectrum  of  miconazole showed  absorption  
bands  at 3215 cm
-1
corresponding to OH group, at 
1515 cm
-1  
and 1560 cm
-1  
corresponding to – NO2 
and at 1180 cm
-1  
and 1360
-1  
cm
-1 
corresponding to C-
N group. The IR spectra of MU 1:8 PM and MU 1:8 
HSD both showed absorption bands corresponding to 
the functional groups of miconazole and urea (both). 
These studies indicate that there is no chemical 
interaction between miconazole and urea. 
The DSC curves of urea, miconazole, exhibited 
endothermic peaks at 135.73
o
C, 162.87
o
C, 127.46
o
C, 
respectively corresponding to their melting points. DSC 
curves of MU 1:8 PM (Fig. 5.12) and MU 1:8 HSD 
showed endothermic peaks at 131.80
o
C and 133.58
o
C, 
respectively. The endothermic peak at 162.87
o
C 
observed in case of miconazole, was absent in case of 
DSC curves of the two formulations of miconazole 
(MU 1:8 PM and MU 1:8 HSD). Both endothermic 
peaks at 131.80
o
C (for MU 1:8 PM) and 133.58
o
C (for 
MU 1:8 HSD) are very close to the endothermic peak of 
urea (at 135.73
o
C). Also, the endothermic peaks at 
131.80
o
C for physical mixture of miconazole and urea 
(MU 1:8 PM) and at 133.58
o
C for hydrotropic solid 
dispersion of miconazole and urea (MU 1:8 HSD) are 
very close to each other. This fact clearly rules out any 
chemical interaction between miconazole and urea (the 
hydrotropic agent). 
 
Fig. 1 to Fig. 6 show the characteristic X-ray diffraction 
patterns recorded for urea and miconazole, the prepared 
hydrotropic solid   dispersion formulations and the physical 
mixture formulations.  The X -ray diffractograms of urea 
and miconazole exhibited a series of intense peaks, which 
were indicative of their crystalline characters. XRD 
diffraction patterns of the hydrotropic solid dispersions MU 
1:8 HSD, TU 1:8 HSD, and the physical mixtures MU 1:8 
PM, PM, TU 1:8 PM also exhibited a series of intense peaks 
which are characteristic peaks of urea and the respective 
drug. The peaks found in case of hydrotropic solid 
dispersions and the respective physical mixtures are quite 
comparable. This study confirmed that hydrotropic solid 
dispersions were not present in amorphous form; rather 
Kaushik et al                                                                                      Journal of Drug Delivery & Therapeutics. 2017; 7(3):117-126                                     
ISSN: 2250-1177                                                                              [125]                                                                            CODEN (USA): JDDTAO 
they are of crystalline nature. 
 
From figures (Fig. 7) of dissolution profiles, it is 
evident that the bulk drug samples exhibited poor drug 
release profiles. Initial rates of dissolution of drugs from 
hydrotropic solid dispersions were very quick  as  
compared  to  initial  rates  of  dissolution from  bulk  
drug  samples.  Physical mixtures also showed slightly 
better drug release profiles compared to drug release 
profiles from respective bulk drug samples. Drug 
release profiles from hydrotropic solid dispersions were 
still better than the drug release profiles from physical 
mixtures. Also, it is indicated that as the proportion of 
water-soluble carrier (urea) was increased in solid 
dispersions there was improvement in dissolution 
behavior. As  the  initial  rates  of dissolution  of  drugs  
from  hydrotropic  solid   dispersions  were  significantly  
high  as compared to initial dissolution rates from bulk 
drug  samples, the quick onset of action and better 
extent of absorption is expected after oral administration 
of these hydrotropic solid dispersions. 
Hydrotropic solid dispersion formulations and physical 
mixture formulations of miconazole were subjected to 
stability studies at room temperature, 40°C/75% RH 
and 55°C for six months (Table 14). The initial drug 
contents of formulations were considered as 100.00%. 
To determine chemical  stability  at  room temperature, 
40°C/75% RH  and  55°C, the  residual drug contents 
of these formulations were determined after 1, 3 and 6 
months of storage. 
The residual drug content after storage for 6 months at 
room temperature in all formulations  was  above  98%  
(much  above  90.00%),  showing  very  good  chemical 
stabilities at room temperature. The residual drug 
contents after storage for 6 months at 40°C/75% RH 
in all formulations was above 96% (much above 
90.00%), showing good chemical stabilities at moderate 
temperature. The residual drug content after storage for 
6 months at 55°C in all formulations was above 
90.00%, showing good chemical stabilities at a higher 
temperature. 
The physical mixtures (of drugs with urea) were 
subjected to chemical stability and the chemical 
stabilities observed were very comparable to the 
chemical stabilities of corresponding hydrotropic solid 
dispersions indicating that the chemical stability was not 
influenced by making respective solid dispersions (with 
urea). 
 
 
 
Figure 1:  X-ray diffractogram of urea 
 
 
Figure 2  X-ray diffractogram of miconazole 
 
 
Figure 3:  X-ray diffractogram of miconazole:urea, 
1:8 hydrotropic solid dispersion 
 
Figure 4:  X-ray diffractogram of miconazole:urea, 
1:8 physical mixture 
 
 
Figure 5:  X-ray diffractogram of miconazole 
 
 
Figure 6:  X-ray diffractogram of urea 
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Figure 7: Dissolution profiles of pure miconazole and its formulations in distilled water 
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